Fuller & Thaler Asset Management Inc. Purchases 274,192 Shares of Encompass Health Co. (NYSE:EHC)

Fuller & Thaler Asset Management Inc. lifted its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 24.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,378,077 shares of the company's stock after buying an additional 274,192 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 1.37% of Encompass Health worth $127,265,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Morse Asset Management Inc bought a new position in shares of Encompass Health in the third quarter worth approximately $68,000. Tidal Investments LLC increased its position in shares of Encompass Health by 5.7% in the third quarter. Tidal Investments LLC now owns 3,509 shares of the company's stock valued at $339,000 after acquiring an additional 188 shares during the period. Synovus Financial Corp raised its stake in shares of Encompass Health by 92.9% during the third quarter. Synovus Financial Corp now owns 16,057 shares of the company's stock valued at $1,552,000 after acquiring an additional 7,733 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of Encompass Health by 22.0% during the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock worth $67,412,000 after purchasing an additional 126,000 shares during the period. Finally, GAMMA Investing LLC grew its stake in shares of Encompass Health by 22.1% in the fourth quarter. GAMMA Investing LLC now owns 1,947 shares of the company's stock worth $180,000 after purchasing an additional 352 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Stock Up 11.8 %

Shares of Encompass Health stock traded up $11.92 during midday trading on Friday, hitting $113.33. The company had a trading volume of 2,076,448 shares, compared to its average volume of 675,826. The company has a 50 day moving average of $100.08 and a 200 day moving average of $98.51. The stock has a market capitalization of $11.41 billion, a P/E ratio of 25.41, a P/E/G ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 52-week low of $82.09 and a 52-week high of $114.27. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. On average, equities analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend was Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Wall Street Analyst Weigh In

EHC has been the subject of several research analyst reports. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays lifted their price target on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday. KeyCorp upped their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a report on Friday. Royal Bank of Canada reaffirmed an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research note on Friday. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $109.11.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.